Monday, 26 Jun 2017

RA/Inflammatory arthritis

Datesort ascending Type Title Save
26 Jan 2017 Social Nearly half of pts believe they know cause of their PMR: age, meds, stress, other medical Dxs; other half "no idea" https://t.co/WJIIj9Wowv
24 Jan 2017 News C5a and Neutrophils as Early Mediators in Inflammatory Arthritis
24 Jan 2017 Social Among 103 SLE pts ~10% had "Rhupus" polyarthritis; they had less renal, but more joints, erosions, hi ESR/CRP levels https://t.co/TpNKquhSVH
23 Jan 2017 Social Creaky Joints publishes Patient’s Guide to Living with Rheumatoid Arthritis written by patients & MDs downloadable https://t.co/65DClwIFKL
19 Jan 2017 Social High neutrophil-lymph ratio (NLR) >4 seen w/ GPA severity w/ renal. Also high w/ RA, CVD, inflammation, smoking, CA https://t.co/kTa5ZqscOU
19 Jan 2017 Social Lyme dz found at 9 US National Parks in Maine: Maryland; Fire Island, NY; Gettysburg Pennsylvania; DC & Virginia https://t.co/SVkrNGvwwZ
18 Jan 2017 Social ARD study shows IL-12 (guselkumab), IL-12/23 (ustekinumab) no more effective than placebo in #RA (41%, 54%, 40%) https://t.co/pOD9ZovCei
17 Jan 2017 Social 141 RA pts studied ESR, CRP, IL6, VEGF, Calprotectin & Jt US. Calprotectin highest assoc w/ US synovitis & response https://t.co/eaRy5YzXpe
15 Jan 2017 Social RT @ArthritisRes: Calprotectin potential marker for evaluating inflammation and responsiveness in patients with RA on bDMARD treatment http…
14 Jan 2017 Social Interstitial fibrosis. look for pleural plaques (asbestosis), calcinosis (PSS) mediastinal LN (silicosis) https://t.co/CNW8TsJuW1
13 Jan 2017 Social If #RA pts have hi levels of IL-17 & restricted IL17 polymorphisms, why NO response to Cosentyx, Taltz, brodalumab? https://t.co/HCbCyxEuBt
12 Jan 2017 News TREG Innovators Win the Crafoord Prize
06 Jan 2017 Social RT @doctorakerkar: Study shows high-fiber diet may reduce #gout inflammation https://t.co/Oln10i6HeJ
05 Jan 2017 Social Among 40,000 Dutch, 1% had ACPA+; 22% had #RA. ACPA assoc w/ being older, female, joint sx, smoking, RA relatives https://t.co/8HuCE3XOtU
05 Jan 2017 Social DMARDs Under Study for Secondary Prevention of Cardiovascular Events | RheumNow - Rheumatology News & Information https://t.co/UxREHR6BwN
30 Dec 2016 Social Myriad faces loss of Medicare pay for RA VECTRA-DA test, based on recent CMS report. THIS HASNT HAPPENED YET. https://t.co/YBx3BqVKeQ
30 Dec 2016 Social Incident RA prevalence=0.63%; 2/3 Rx w/ DMARD, but 28% were not. 38% @1yr & 15% @2yr never seen by Rheumatologist https://t.co/haqDyRAxCN
28 Dec 2016 Social Claims data >500K people in metro areas shows 58% RA pts see a RHEUM, 64% Rx a DMARD, 30% biologic pts had TB screen https://t.co/0lVzxCtdEW
26 Dec 2016 Social Vectra disappointed in MolDx program draft non-coverage decision for Vectra (CMS price $587) based on AMPLE study https://t.co/eDO4toKSkq
24 Dec 2016 Social United Rheumatology GPO new practice guidelines for RA endorses use of Vectra DA;stating ~60% Rheums ordered VECTRA) https://t.co/KhIQjmGjPf